Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07100730 |
| Title | Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma (IPAX BrIGHT) |
| Acronym | IPAX BrIGHT |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Telix Pharmaceuticals (Innovations) Pty Limited |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Gold Coast University Hospital | RECRUITING | Gold Coast | Queensland | Australia | Details | |
| Austin Health | RECRUITING | Melbourne | Australia | Details | ||
| Royal North Shore Hospital | NOT_YET_RECRUITING | Sydney | Australia | Details |